abstract |
The present invention relates to a short acting hypnotic agent selected from GABA-A receptor modulators, benzodiazepines, phenothiazines, melatonin derivatives and melatonin receptor agonists for the treatment of sleep disorders; GABA-A receptor modulators, It relates to a combination with a long acting hypnotic agent selected from 5HT2A receptor antagonists and calcium ion modulators. Moreover, this invention relates to the galenical formulation containing the said combination. |